Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2576897

IR number 1870469
Words AZURITY
Image
Image description
Status protected: Registered/protected
Priority date 06 Jun 2025 (Convention)
Class 5
Kind Word
Dates
Renewal due 16 Jun 2035
Registration advertised / published 14 Jan 2026
Entered on Register 14 Jan 2026
Acceptance advertised / published 07 Nov 2025
Acceptance 22 Aug 2025
IR notification 14 Aug 2025
Filing 16 Jun 2025
Registered from 16 Jun 2025

Owner Address for service
Azurity Pharmaceuticals, Inc.

IR Contact

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.


Goods & Services
Class 5: Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders; pharmaceuticals for use in the treatment and prevention of respiratory, immunology, endocrinology, allergy diseases and disorders; imaging agents.

Convention details
Date 06 Jun 2025
Number 99221641
Country UNITED STATES OF AMERICA
Goods & Services
Class 05:
pharmaceuticals for use in the treatment and prevention of respiratory, immunology, endocrinology, allergy diseases and disorders; imaging agents

Indexing constituents
Word Image